sophocarpine has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, D; Yang, YS; Zhao, XF | 1 |
| Hu, Z; Li, Y; Wang, S; Xiao, Z; Zhang, J; Zhang, Y | 1 |
2 other study(ies) available for sophocarpine and Cancer of Colon
| Article | Year |
|---|---|
Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Oxaliplatin | 2021 |
Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice.
Topics: Adenocarcinoma; Alkaloids; Animals; Cachexia; Cell Line; Colonic Neoplasms; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Matrines; Mice; Mice, Inbred BALB C; Quinolizines; Tumor Necrosis Factor-alpha | 2008 |